Article

Leveraging Neural Network Models for Drug Repurposing: A case study on Cardiac Hypertrophy

2025-01-29

Abstract excerpt

<h4>Background</h4> Drug repurposing has emerged as an attractive strategy in contemporary pharmaceutical research, presenting an opportunity to expedite drug discovery, minimize developmental costs, and mitigate risks associated with developing new pharmaceuticals. In this study, we investigated a novel approach based on deep learning of human transcriptomic mechanisms for systematic identification of additional...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c3800e30-b00d-580c-8d9f-ad8f9269afae
DOI: 10.1101/2025.01.28.635194

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Leveraging Neural Network Models for Drug Repurposing: A case study on Cardiac HypertrophyDOI 10.1101/2025.01.28.635194Read

From Transcriptomic Signatures to Active-Site Docking and ADMET Properties Prediction: Bioinformatics-Guided Exploration of Binding Mechanisms of Cardioprotective Phytoconstituents Against Dysregulated Targets in Hypertrophic CardiomyopathySemantic proximity Read

Utilizing Pre-trained Network Medicine Models for Generating Biomarkers, Targets, Re-purposing Drugs, and Personalized Therapeutic Regimes: COVID-19 ApplicationsSemantic proximity Read

Network machine learning maps phytochemically-rich “Hyperfoods” to fight COVID-19Semantic proximity Read

Novel graph attention autoencoder framework with multilayered validation identifies drug repurposing candidates for COVID-19 treatmentSemantic proximity Read

Identification of targets for drug repurposing to treat COVID-19 using a Deep Learning Neural NetworkSemantic proximity Read

Advancing Efficacy Prediction for EHR-based Emulated Trials in Repurposing Heart Failure TherapiesSemantic proximity Read

Mining transcriptomics and clinical data reveals ACE2 expression modulators and identifies cardiomyopathy as a risk factor for mortality in COVID-19 patientsSemantic proximity Read

A deep generative model for deciphering cellular dynamics and in silico drug discovery in complex diseasesSemantic proximity Read

A cross-species multimodal database of gene expression in cardiac hypertrophySemantic proximity Read

Deciphering epistatic genetic regulation of cardiac hypertrophySemantic proximity Read

AI-Driven Predictive Biomarker Discovery with Contrastive Learning to Improve Clinical Trial OutcomesSemantic proximity Read

Network machine learning maps phytochemically rich “Hyperfoods” to fight COVID-19Semantic proximity Read